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Abstract 
 
The anti-inflammatory and antinociceptive activities of Triphala recipe were studied in animal models. Triphala 
recipe (4 mg/ear) significantly exhibited an inhibitory effect on the ear edema formation induced by ethyl phenylpropiolate-
induced, but not on the arachidonic acid -induced ear edema in rats. Furthermore, Triphala recipe at the doses of 300, 600 and 
1,200 mg/kg significantly reduced carrageenan-induced hind paw edema. Next, the anti-inflammatory action in chronic 
inflammation was measured using the cotton pellet-induced granuloma formation assay in rats. Triphala recipe (1,200 mg/kg) 
reduced neither transudative weight nor granuloma formation.  It also did not affect on body weight gain and thymus weight 
indicating that Triphala recipe does not have a steroid-like effect. In antinociceptive study, Triphala recipe (300, 600, 1,200 
mg/kg), elicited significant inhibitory effect on both phases, especially in late phase, of the formalin test in mice suggesting 
that the antinociceptive action of Triphala recipe may be via both peripheral and at least partly centrally acting. 
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Introduction 
 
Triphala has commonly been used in an Ayurvedic and Thai traditional medicine. It consists of the dried fruits of 
three plants, Phyllanthus emblica Linn., Terminalia chebula Retz., and Terminalia bellerica (Gaertn.) Roxb. Triphala recipe 
is a botanical preparation comprised of equal proportions of the three herbal fruits. It is used for adjusting the balance of four 
elements of the body and detoxifying the body systems, especially the gastrointestinal system, blood and lymph systems. 
Thai traditional medicine doctors use this recipe to removing waste products (i.e. fecal matter, urine and sweat).  
Triphala recipe possesses many biological activities including antimutagenic (Kaur et al., 2002), radioprotective 
(Sandhya et al., 2006a), hypocholesterolaemic (Saravanan et al., 2007), immunomodulatory (Srikumar et al., 2005), 
anticancer (Deep et al., 2005; Sancheti et al., 2005; Sandhya and Mishra, 2006; Sandhya et al., 2006b), and anti-oxidant 
activities (Naik et al., 2005). Moreover, this recipe has an anti-inflammatory activity on adjuvant-induced arthritis in mice 
(Rasool and Sabina, 2007). 
However, there are a few reports regarding the anti-inflammatory and antinociceptive activities of this recipe. The 
objective of this study was thus to evaluate the anti-inflammatory and antinociceptive activities of Triphala recipe using 
animal models. 
 
Materials and Methods 
Preparation of Triphala recipe 
 
In our laboratory, a decoction of each plant raw materials (P. emblica, T. chebula and T. bellerica) was developed 
as follows: the raw material was immersed in 100 liters of water for 30 min, then boiled for 1 hour and filtered to remove the 
residue. Next, the aqueous extract was repeatedly boiled and filtered twice. Next, spray drying process was carried out to 
remove any residual trace of the extraction solvent in the extract.  The extract was standardized by thin layer chromatography 
(TLC) and high performance liquid chromatography (HPLC). Each aqueous extract was stored at -20C until the preparation 
of Triphala recipe. Triphala recipe was further prepared from a mixture containing one kilogram of each extract.  
 
Experimental animals 
 
Male ICR albino mice (30-40 g) and male Sprague Dawley rats (40-60 g, 100-120 g, 200-220 g) were procured 
from the National Laboratory Animal Center, Nakorn Pathom, Thailand. The animals were housed a temperature-controlled 
room (25 ± 1 C) and provided with standardized pelleted feed and clean drinking water ad libitum. The study has got the 
clearance from the Animal Ethics Committee of Faculty of Medicine, Thammasat University, Pathum Thani, Thailand (No. 
0001/2008). 
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Ethyl phenylpropiolate (EPP) or arachidonic acid (AA)-induced ear edema in rats 
 
Male rats (40-60 g) were used and the ear edema was produced by topical application of EPP (1 mg/20 l/ear) or 
AA (2 mg/20 l/ear) to the inner and outer surface of both ears. Triphala recipe (4 mg/ear), phenylbutazone (1 mg/ear), 
phenidone (2 mg/ear) and vehicle (the mixture of dimethysulfoxide and acetone, 1:1) were applied in the same manner in a 
volume of 20 l just before the irritants. The edema thickness was measured with digital vernier calipers at 0, 15, 30, 60, and 
120 min after EPP induction and at 60 min after AA induction. 
 
Carrageenan-induced paw edema in rats  
Five groups of male rats (100-120 g) containing six animals per group orally received distilled water (control, 2 
ml/kg), Triphala recipe (300, 600 and 1,200 mg/kg) and aspirin (300 mg/kg). One hour after orally administration of test 
substance, acute inflammation was produced by an intradermal injection of carrageenan (1% in normal saline solution, NSS) 
into the plantar surface of the right hind paw of the rat at a volume of 0.05 ml. The paw edema volume was measured using a 
plethysmometer (model 7140, Ugo Basile, Italy) at 0, 1, 3 and 5 hours after carrageenan injection.  
 
Cotton pellet-induced granuloma formation in rats 
 
Four groups of male rats (200-220 g, n=6) were used. The distilled water (control, 2 ml/kg), aspirin (300 mg/kg), 
prednisolone (5 mg/kg) and Triphala recipe (1,200 mg/kg) were orally given to the rats. One hour after, the animals under 
ether anesthesia were implanted subcutaneously with two sterilized cotton pellets (20 ± 1 mg), one on each side of the 
abdomen. The test substances were administered orally in a once daily dosage regimen throughout the experimental period of 
7 days. On the eighth day, each rat was anaesthetized with thiopental sodium (40 mg/kg). The cotton pellets and thymus were 
removed, dried at 60 C for 18 h and their dry weight determined. The change in body weight from the first and the last day 
of experiment was also recorded. The transudative and granuloma weight, as well as the percent granuloma inhibition of the 
test drugs were calculated. 
 
Formalin test  
 
Male ICR mice were used and divided into 6 groups and treated respectively with Triphala (300, 600, 1,200 
mg/kg), aspirin (300 mg/kg), and distilled water (control, 1 ml/kg). One hour later, 1% formalin in NSS (20 l) was injected 
subcutaneously into the left hand foot pad, immediately placed in a transparent plastic cage separately; the licking time were 
recorded for 5 min after formalin injection for early phase. In the late phase assessment, another set of mice were used. The 
formalin was injected 40 min after oral administration of test substance and the licking time was determined between 20 and 
30 min after the injection of formalin  
 
Statistical analysis 
 
Results were expressed as mean ± standard error of mean (S.E.M.). Statistical significance was determined by one-
way analysis of variance (ANOVA) and post hoc least-significant difference (LSD) test. P values less than 0.05 were 
considered significant. 
 
 
Results and discussion  
 
The inhibitory effect of Triphala recipe on EPP-induced ear edema is shown in Figure 1A. Inflammation in EPP 
model involves instant irritation which leads to fluid accumulation and edema characteristic. The inflammatory mediators 
released in this model are histamine, serotonin, bradykinin and prostaglandins (PGs), and these mediators are capable of 
promoting vasodilatation and increasing vascular permeability as well as producing edema (Brattsand et al., 1982; Carlson et 
al., 1985). Triphala recipe (4 mg/ear) and phenylbutazone (1 mg/ear) significantly reduced the edema thickness at all 
assessment times.  
AA-induced ear edema is an inflammation model which is used to evaluate the anti-inflammatory activity of 
lypoxygenase inhibitors (Young et al., 1984; Opas et al., 1985). AA causes an increase in LTB4, LTC4, and PGE2 contents in 
ear tissue (Horizoe et al., 1998) and especially LOX metabolites which are major mediators of the inflammatory process 
(Chang et al., 1986; Di Martino et al., 1987). Triphala recipe (4 mg/ear) showed no inhibitory effect on AA-induced ear 
edema (Figure 1B).  Since Triphala recipe exhibited an inhibitory effect on the ear edema formation induced by EPP, but not 
on the AA-induced ear edema, these indicate the anti-inflammatory activity of Triphala recipe does not involve the 
lipoxygenase pathway. 
Sireeratawong et al., Afr J Tradit Complement Altern Med. (2013) 10(2):246-250 
http://dx.doi.org/10.4314/ajtcam.v10i2.8 
248 
 
 
Figure 1 Inhibitory effect of Triphala recipe on edema thickness of EPP (A) or AA (B) induction in rats. *Significantly 
different from the control group, p<0.05. 
 
Carrageenan-induced hind paw edema is successfully used for identifying inhibitors of cyclooxygenase (Winter et 
al., 1962). Inflammatory formation of carrageenan involves two distinct phases of mediator release. Histamine, serotonin and 
bradykinin are released in first phase which occurs between 0 and 2 h after carrageenan injection. In late phase, the 
inflammation reaches it maximum approximately 3 h after carrageenan injection and then it begins to decline. The releasing 
of prostaglandin in late phase is the cause of edema which depends on the mobilization of neutrophils (Di Rosa et al., 1971). 
In our study, Triphala recipe at the doses of 300, 600 and 1,200 mg/kg significantly reduced the paw edema volume at all 
assessment times when compared with the control group as shown in Figure 2. The inhibitory effect of Triphala recipe on 
carrageenan-induced paw edema at the 3rd hour suggests that the action of Triphala recipe may involve the inhibition of the 
synthesis or the release of prostaglandins.  
 
 
Figure 2: Inhibitory effect of Triphala recipe on paw edema volume of carrageenan induction in rats 
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Anti-inflammatory action in chronic inflammation was demonstrated by the ability to inhibit the increase of 
number of fibroblasts during granuloma tissue formation (Gupta et al., 2003). In this experiment, Triphala recipe did not 
reduce transudative weight and granuloma formation (Table 2). The obtained result suggests that Triphala recipe does not 
possess the inhibitory effect on granuloma formation. In addition, Triphala recipe did not affect on body weight gain and 
thymus weight indicating that Triphala recipe does not have a steroid-like effect (Table 3). 
 
Table 2: Effect of Triphala recipe on granuloma formation and transudation in cotton pellet-induced granuloma formation in 
rats 
Group Transudative weight (mg) Granuloma weight 
(mg/mg cotton) 
GI (%) 
5% Tween80 427.39 ± 50.21 3.55 ± 0.41 - 
Prednisolone 5 mg/kg 263.40 ± 17.10* 2.59 ± 0.25* 27 
Aspirin 300 mg/kg 339.52 ± 17.82 2.97 ± 0.24 16 
Triphala 1,200 mg/kg 340.92 ± 24.37 2.87 ± 0.19 19 
Data represent mean  S.E.M. (n=6).  
*Significantly different from the control group, p<0.05 
GI = granuloma inhibition 
 
 
 
Table 3: Effect of Triphala recipe on body weight and thymus weight in cotton pellet-induced granuloma formation in rats 
Body weight (gram) Group 
Initial Final Gain 
Dry thymus weight 
(mg/100g) 
5% Tween80 384.2 ± 20.5 392.5 ± 20.1 8.33 ± 2.47 22.2 ± 1.4 
Prednisolone 5 mg/kg 357.5 ± 115 349.2 ± 11.8* -8.33 ± 4.94* 17.1 ± 0.8* 
Aspirin 300 mg/kg 368.3 ± 13.8 365.0 ± 12.2 -3.33 ± 2.79 19.2  ± 1.3 
Triphala 1,200 mg/kg 361.7 ± 12.4 358.3 ± 15.4 -3.33 ± 7.49 23.5  ± 1.1 
Data represent mean ± S.E.M. (n=6).  
*Significantly different from the control group, p<0.05 
The formalin test is a well described model of nociception which consisted of two distinct phases. The nociception 
in early phase is due to the direct stimulation of the sensory nerve fibers by formalin which can be inhibited by centrally 
acting antinociceptives (Hunskaar et al., 1985; Hunskaar and Hole, 1987). The late phase response is due to inflammatory 
mediators such as histamine, prostaglandins, serotonin and bradykinin (Murray et al. 1988, Tjolsen et al. 1992, Dharmasiri et 
al. 2003). This phase can be inhibited by NSAIDs (aspirin, indomethacin and naproxen) and steroids (dexamethasone and 
hydrocortisone) as well as the centrally acting drugs (Hunskaar and Hole, 1987). 
In the present study, the licking of foot was triggered by subcutaneous injection of formalin into the hand foot pad. 
Triphala recipe (300, 600, 1,200 mg/kg), aspirin (300 mg/kg) and morphine (10 mg/kg) elicited significant inhibitory effect 
on both phases of the formalin test in mice, especially in late phase as shown in Figure 3. The antinociceptive activity of 
Triphala recipe in the early phase may be the centrally acting mechanism. The activity of Triphala recipe found in late phase 
rather indicates the inhibitory effect on the synthesis and/or release of inflammatory pain mediators especially prostaglandins. 
 
 
           Figure 3: Inhibitory effect of Triphala recipe on licking response of formalin test in mice 
 
In conclusion, Triphala recipe has both the anti-inflammatory and antinociceptive activities. The former effect is 
perhaps mediated via inhibition of cyclooxygenase pathway, and free of steroidal-like action. The antinociceptive activity of 
Triphala recipe may be via both peripheral acting and partly central acting.  
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